Outcomes from Fecal Microbiota Transplantation in Adults with C. difficile Infection and Inflammatory Bowel Disease
Sahil Khanna(Mayo Clinic), Darrell S. Pardi(Mayo Clinic), Patricia P. Kammer(Mayo Clinic), John F. Rainey(Mayo Clinic), Edward V. Loftus(Mayo Clinic), Purna Kashyap(Mayo Clinic)
Cited by 2
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells
|The FASEB Journal|2014|1.3k
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
|Nature|2013|1.1k
US Immigration Westernizes the Human Gut Microbiome
|Cell|2018|850